EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RETRACTED: African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2′3′-cGAMP

Lakmal Ranathunga iD, Niranjan Dodantenna, Ji-Won Cha, Kiramage Chathuranga, W A Gayan Chathuranga, Asela Weerawardhana, Ashan Subasinghe, D K Haluwana, Nuwan Gamage, Jong-Soo Lee iD

Journal of Virology · 30.11.2023 · 97 (11)

DOI: 10.1128/jvi.00795-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 30.11.2023. Verfasst von Lakmal Ranathunga und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Chungnam National University , Daejeon, South Korea. Hauptthemen laut MEDLINE: African Swine Fever, African Swine Fever Virus, Interferon Type I, Membrane Proteins. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Environment (MOE), National Research Foundation of Korea (NRF), Korea Research Institute of Bioscience and Biotechnology (KRIBB).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type I interferon (IFN)-mediated responses operate a pivotal role in the first line of host immune defense against viruses. Upon DNA virus infection, DNA sensing cyclic GMP-AMP synthase-STING signal pathway is a key event in the IFN-mediated antiviral response and also a target of viral immune evasion. African swine fever (ASF) is a highly contagious, cross-border viral disease that often confers fatalities in domestic and feral pigs of all ages. African swine fever virus (ASFV), a causative agent of ASF, is a nucleocytoplasmic large DNA virus that masks critical elements of host immune system by several encoded proteins. In this study, we report a novel immune evasion mechanism of ASFV B175L to block type I IFN signaling by targeting STING and 2'3'-cyclic GMP-AMP (2′3′-cGAMP). We found that ASFV B175L significantly inhibited the DNA virus-induced IFN-β production and IFN-mediated signaling responses. The conserved zf-FCS motif of ASFV B175L competitively interacted with both cGAMP and the cyclic dinucleotide binding domain of STING. Remarkably, the R238 and Y240 amino acids of STING were crucial for interaction with ASFV B175L. Consequently, this interaction inhibits the interaction between cGAMP and STING, thereby inhibiting downstream signaling including STING polymerization and phosphorylation of TANK-binding kinase 1 and interferon regulatory factor 3 for antiviral signaling. Taken together, these results highlight the critical role of ASFV B175L in suppression of IFN responses and provide a new target to guide live-attenuated ASFV vaccine. IMPORTANCE African swine fever virus (ASFV), the only known DNA arbovirus, is the causative agent of African swine fever (ASF), an acutely contagious disease in pigs. ASF has recently become a crisis in the pig industry in recent years, but there are no commercially available vaccines. Studying the immune evasion mechanisms of ASFV proteins is important for the understanding the pathogenesis of ASFV and essential information for the development of an effective live-attenuated ASFV vaccines. Here, we identified ASFV B175L, previously uncharacterized proteins that inhibit type I interferon signaling by targeting STING and 2′3′-cGAMP. The conserved B175L-zf-FCS motif specifically interacted with both cGAMP and the R238 and Y240 amino acids of STING. Consequently, this interaction interferes with the interaction of cGAMP and STING, thereby inhibiting downstream signaling of IFN-mediated antiviral responses. This novel mechanism of B175L opens a new avenue as one of the ASFV virulent genes that can contribute to the advancement of ASFV live-attenuated vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

African Swine FeverAfrican Swine Fever VirusInterferon Type IMembrane ProteinsNucleotides, CyclicSwineViral ProteinsAnimalsVaccines, AttenuatedViral VaccinesHost Microbial Interactions

Stichwörter der Autor:innen

2′3′-cGAMPAfrican swine fever virus (ASFV)B175LSTING and type I interferon

Substanzen

cyclic guanosine monophosphate-adenosine monophosphateInterferon Type IMembrane ProteinsNucleotides, CyclicVaccines, AttenuatedViral ProteinsViral Vaccines

Autor:innen und Institutionen

  • College of Veterinary Medicine, Chungnam National University , Daejeon, South Korea.

ORCID-Profile: Lakmal Ranathunga, Jong-Soo Lee

Förderung

  • Ministry of Environment (MOE)
  • National Research Foundation of Korea (NRF)
  • Korea Research Institute of Bioscience and Biotechnology (KRIBB)
  • Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea

Zitieren

APA

Ranathunga, L., Dodantenna, N., Cha, J. W., Chathuranga, K., Chathuranga, W. A. G., Weerawardhana, A., Subasinghe, A., Haluwana, D. K., Gamage, N., & Lee, J. S. (2023). RETRACTED: African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2′3′-cGAMP. Journal of Virology, 97(11). https://doi.org/10.1128/jvi.00795-23

Vancouver

Ranathunga L, Dodantenna N, Cha JW, Chathuranga K, Chathuranga WAG, Weerawardhana A, et al. RETRACTED: African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2′3′-cGAMP. Journal of Virology. 2023;97(11). doi:10.1128/jvi.00795-23

BibTeX
@article{Ranathunga2023,
  author = {Ranathunga, Lakmal and Dodantenna, Niranjan and Cha, Ji-Won and Chathuranga, Kiramage and Chathuranga, W A Gayan and Weerawardhana, Asela and Subasinghe, Ashan and Haluwana, D K and Gamage, Nuwan and Lee, Jong-Soo},
  title = {RETRACTED: African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2′3′-cGAMP},
  journal = {Journal of Virology},
  year = {2023},
  volume = {97},
  number = {11},
  doi = {10.1128/jvi.00795-23}
}
Kostenlos starten →